Strategy and validation of a structure-based method for the discovery of selective inhibitors of PAK isoforms and the evaluation of their anti-cancer activity-Reference-Cited by-同舟云学术

Strategy and validation of a structure-based method for the discovery of selective inhibitors of PAK isoforms and the evaluation of their anti-cancer activity

Published:2019-10 Issue: Volume:91 Page:103168
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Song Pei-Lu,Wang Gang,Su Yuan,Wang Han-Xun,Wang Jian,Li Feng,Cheng Mao-Sheng

Funder

Natural Science Foundation of Liaoning Province

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference35 articles.

1. A brain serine/threonine protein kinase activated by Cdc42 and Rac1;Manser;Nature,1994

2. A tale of two Paks;Arias-Romero;Biol. Cell,2008

3. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells;Zhang;Cancer Lett.,2012

4. PAK signalling during the development and progression of cancer;Radu;Nat. Rev. Cancer,2014

5. Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines;Callow;J. Biol. Chem.,2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico approaches for drug repurposing in oncology: a scoping review;Frontiers in Pharmacology;2024-06-11

2. Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease;Future Science OA;2023-04

3. Biological role of the PAK4 signaling pathway: A prospective therapeutic target for multivarious cancers;Arabian Journal of Chemistry;2023-01

4. PAK4 in cancer development: Emerging player and therapeutic opportunities;Cancer Letters;2022-10

5. Differential roles and regulation of the protein kinases PAK4, PAK5 and PAK6 in melanoma cells;Biochemical Journal;2022-08-31